CESTAT Delhi Clarifies Customs Classification of Blood Glucose Meters

Aadrikaa Legal Services (ALS) – IDT Tax I Arbitration I Litigation

Date: 18.05.2026

CESTAT Delhi Clarifies Customs Classification of Blood Glucose Meters

Blood glucose meters, commonly known as glucometers, are essential medical devices used for monitoring blood sugar levels. The classification of these devices under Indian customs law has significant implications for import duty and tax exemptions. A recent order by the Customs, Excise & Service Tax Appellate Tribunal (CESTAT) in New Delhi has clarified the correct classification and duty assessment for these instruments, impacting importers and the healthcare industry.

Background of the Case

Aspen Diagnostics Pvt Ltd, a company specializing in laboratory and patient care equipment, imported blood glucose meters, urine analyzers, and other diagnostic devices between September 2020 and December 2021. The company classified these goods under Customs Tariff Item (CTI) 9027 80 90, which allowed them to claim a nil rate of basic customs duty under Notification No.24/2005-cus. They also paid Integrated Goods and Service Tax (IGST) at rates specified in relevant notifications:

• Glucometers: 12% IGST
• Other diagnostic goods: 18% IGST

Dispute and Arguments

The customs authorities challenged Aspen Diagnostics’ classification, arguing that blood glucose meters should be classified under CTI 9018 90 99, which covers medical diagnostic instruments. This reclassification would result in higher duties and penalties. Aspen Diagnostics contested this, citing previous tribunal decisions, particularly the Bayer Pharmaceuticals Pvt. Ltd. case, which classified glucometers under CTI 9027 80 90 as instruments for chemical analysis.

Tribunal’s Analysis and Ruling

The tribunal examined the competing tariff headings:

1. Heading 9027: Instruments and apparatus for physical or chemical analysis (e.g., spectrometers, gas analysis apparatus).
2. Heading 9018: Instruments and appliances used in medical, surgical, dental, or veterinary sciences.

Key points from the tribunal’s reasoning:

• The essential function of a glucometer is to draw blood and analyze it for glucose content, which constitutes chemical analysis.
• Glucometers are widely used by individuals at home, not just by medical professionals, making them distinct from devices covered under Heading 9018.
• The Harmonized System of Nomenclature (HSN) Explanatory Notes support classification under Heading 9027 for instruments used in laboratories or for chemical analysis.
• Previous decisions (Bayer Pharmaceuticals and Abbott Healthcare) and affirmation by the Supreme Court reinforce this classification.

Outcome and Implications

The tribunal set aside the customs authority’s order, confirming that blood glucose meters are to be classified under CTI 9027 80 90. This classification entitles importers to duty exemptions under Notification No.24/2005-cus, reducing costs and supporting wider access to these essential devices.

Practical Impact

• Importers: Can continue to classify glucometers under CTI 9027 80 90 and claim duty exemptions.
• Healthcare Providers: Benefit from lower costs and easier access to diagnostic devices.
• Regulatory Clarity: The decision provides clear guidance for future imports and customs assessments.

Conclusion

The CESTAT Delhi order is a landmark decision for the classification of blood glucose meters and similar diagnostic instruments. By affirming their status as instruments for chemical analysis, the tribunal has ensured favorable duty treatment and regulatory clarity for importers and the healthcare sector.

Source: CESTAT Delhi

Disclaimer

Handy Download:

Write to us at office@aadrikaalaw.com

Tel: +91-11-4999 2707 I +91-9999005379

www.aadrikaalaw.com